Sign in
Nanoscale plasmonics begins to unravel Alzheimer’s disease
Magazine article   Peer reviewed

Nanoscale plasmonics begins to unravel Alzheimer’s disease

Amanda J Haes, W. Paige Hall and Richard P Van Duyne
Laser focus world
06/01/2005

View Online

Abstract

An optical sensor based on localized surface-plasmon-resonance spectroscopy is ­designed to detect a variety ­ of ligands, including a biomarker for Alzheimer’s disease that is crucial in the development of an Alzheimer’s clinical diagnostic test.
Nanotechnology Alzheimer's disease Technology application

Details

Metrics

13 Record Views